Cuban epidemic neuropathy: insights into the toxic-nutritional hypothesis through international collaboration - Gonz ález-Quevedo A, Santiesteban-Freixas R, Eells JT, Lima L, Sadun AA.
From 1991 to 1993, an epidemic of optic and peripheral neuropathy-the largest of the century-broke out in Cuba, affecting more than 50,000 people. Initially the main clinical features were decreased visual acuity, central and cecocentral scotomas, impaired... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
Peripheral Neuropathy Common in Childhood Cancer Survivors
TUESDAY, May 15, 2018 -- Childhood cancer survivors frequently have clinical abnormalities attributable to peripheral neuropathy, according to a study published online May 14 in JAMA Neurology.
Tejaswi Kandula, M.B.B.S., from the University of New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 15, 2018 Category: Pharmaceuticals Source Type: news
Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer
(JAMA Network) A new study assesses chemotherapy-induced peripheral neuropathy in 121 long-term survivors of childhood cancer to detail clinical, functional, neurophysiological and patient-reported outcomes of the condition. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news
Diagnosing, treating neuropathy symptoms in cancer patients not exact science
(University of Michigan) Most of the roughly 15.5 million cancer survivors in the US receive chemotherapy, and roughly 65 percent develop some degree of the chemotherapy-induced nerve damage known as peripheral neuropathy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2018 Category: International Medicine & Public Health Source Type: news
Peripheral neuropathy is associated with more frequent falls in Parkinson's disease - Beaulieu ML, M üller MLTM, Bohnen NI.
INTRODUCTION: Peripheral neuropathy is a common condition in the elderly that can affect balance and gait. Postural imbalance and gait difficulties in Parkinson's disease (PD), therefore, may stem not only from the primary neurodegenerative process but als... (Source: SafetyLit)
Source: SafetyLit - April 11, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Medical News Today: What could cause tingling in the feet or hands?
A feeling of tingling in the feet or hands can have a variety of causes. Many are related to peripheral neuropathy or nerve damage, but others include a pinched nerve, pregnancy, and even anxiety. Treatments depend on the underlying cause. Learn more about the numerous causes and related symptoms of the condition here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 6, 2018 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news
Effects of Cryotherapy on Paclitaxel-Induced Neuropathy Effects of Cryotherapy on Paclitaxel-Induced Neuropathy
Wearing frozen flexible gloves and socks during infusion may reduce symptoms of paclitaxel-induced peripheral neuropathy.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
NanOlogy looks to transform chemotherapy with localized delivery platform
Paclitaxel revolutionized cancer treatment when it was first used as a chemotherapeutic in the 1990s. But although the product is a powerful cancer killer, patients taking systemic doses of paclitaxel have to endure side effects such as peripheral neuropathy and hair loss.
Marc Iacobucci and his team at NanOlogy believe they could replace the need for large, systemic doses of paclitaxel with the company’s unique formulation technique. NanOlogy has developed a way to turn drugs such as paclitaxel and docetaxel into sub-micron particles of pure drug that can be delivered locally to tumors.
Get the full story at our siste...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals nanology Source Type: news
Gluten free diet nearly eliminates nerve pain for some
Researchers at the University of Sheffield in Sheffield, United Kingdom found a glutren-free diet could help prevent pain associated with peripheral neuropathy, a nerve condition. (Source: the Mail online | Health)
Source: the Mail online | Health - February 28, 2018 Category: Consumer Health News Source Type: news
HDAC6 inhibitors protect against neuronal damage and have therapeutic potential
(VIB (the Flanders Institute for Biotechnology)) Inhibiting HDAC6 improves the structural stability of cells and protects against neuronal damage. Leuven research uncovered that targeting this mechanism could be a promising therapeutic approach for peripheral neuropathies, whether due to Charcot-Marie-Tooth disease (CMT) or as a side effect of chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 8, 2018 Category: International Medicine & Public Health Source Type: news
Supplements and Chemotherapy-Induced Peripheral Neuropathy Supplements and Chemotherapy-Induced Peripheral Neuropathy
Do multivitamins mitigate development of chemotherapy-induced peripheral neuropathy?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
MDI Biological Laboratory discovery could lead to new therapies for diabetics
(Mount Desert Island Biological Laboratory) New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes. The significance of the identification of a common molecular mechanism is that the drug candidates she identified to treat chemotherapy-induced peripheral neuropathy could potentially be used to treat peripheral neuropathy caused by diabetes as well. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 11, 2018 Category: Cancer & Oncology Source Type: news
How Does Pediatric Sj ö gren Syndrome Present?
Discussion
Sjögren Syndrome (SS) is named for Swedish ophthalmologist Henrik Sjögren who published a case series in 1933 describing patients with dry eyes and arthritis. SS is a “chronic autoimmune inflammatory exocrinopathy” that is characterized by lymphocytic infiltration of the lacrimal and salivary glands and has various degrees of systematic involvement. Keratoconjunctivitis sicca and xerostomia are the main clinical symptoms.
Sicca is a Latin word meaning dry. Dryness of the eyes and mouth without evidence of autoimmune disease is called Sicca syndrome or Sicca complex. SS can be primary or se...
Source: PediatricEducation.org - December 11, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Spinal-Cord Stimulation: Durable Pain Relief for Diabetic Neuropathy Spinal-Cord Stimulation: Durable Pain Relief for Diabetic Neuropathy
Implanting a spinal-cord stimulator can offer long-term pain relief to patients with painful diabetic peripheral neuropathy, with the majority still using their device after 5 years, say Dutch researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Researchers test first drug to prevent the onset of chemotherapy-induced neuropathy
(IDIBELL-Bellvitge Biomedical Research Institute) Peripheral neuropathy is a very common side-effect of chemotherapy and may eventually lead to early discontinuation of treatment.Collaboration between research and industry led to the identification and successful testing of a new molecule capable of preventing this neurological complication.This molecule could potentially become the first existing treatment to prevent this frequent adverse effect and improve the quality of life of cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 24, 2017 Category: Cancer & Oncology Source Type: news
